PDGF Receptor β Is a Potent Regulator of Mesenchymal Stromal Cell Function
Open Access
- 1 September 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 23 (9) , 1519-1528
Abstract
Mesenchymal stromal cells (MSCs) in bone marrow are important for bone homeostasis. Although platelet-derived growth factor (PDGF) has been reported to be involved in osteogenic differentiation of MSCs, the role remains controversial and the network of PDGF signaling for MSCs has not been clarified. To clarify the underlying regulatory mechanism of MSC functions mediated by PDGF, we deleted the PDGF receptor (PDGFR)β gene by Cre-loxP strategy and examined the role of PDGF in osteogenic differentiation of MSCs and fracture repair. In cultured MSCs, the mRNA expression of PDGF-A, -B, -C, and -D as well as PDGFRα and β was detected. Depletion of PDGFRβ in MSCs decreased the mitogenic and migratory responses and enhanced osteogenic differentiation as evaluated by increased alkaline phosphatase (ALP) activity and mRNA levels of ALP, osteocalcin (OCN), bone morphogenetic protein (BMP) 2, Runx2, and osterix in quantitative RT-PCR. PDGF-BB, but not PDGF-AA, inhibited osteogenic differentiation accompanied by decreased ALP activity and mRNA levels, except for BMP2. These effects of PDGF-BB were eliminated by depletion of PDGFRβ in MSCs except that PDGF-BB still suppressed osterix expression in PDGFRβ-depleted MSCs. Depletion of PDGFRβ significantly increased the ratio of woven bone to callus after fracture. From the combined analyses of PDGF stimulation and specific PDGFRβ gene deletion, we showed that PDGFRβ signaling distinctively induces proliferative and migratory responses but strongly inhibits osteogenic differentiation of MSCs. The effects of PDGFRα on the osteogenic differentiation were very subtle. PDGFRβ could represent an important target for guided tissue regeneration or tissue engineering of bone.Keywords
This publication has 35 references indexed in Scilit:
- Imatinib Promotes Osteoblast Differentiation by Inhibiting PDGFR Signaling and Inhibits Osteoclastogenesis by Both Direct and Stromal Cell-Dependent MechanismsJournal of Bone and Mineral Research, 2007
- Inhibition of platelet‐derived growth factor receptorβ by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitroCell Proliferation, 2007
- Tissue‐engineered Approach for the Treatment of Steroid‐induced Osteonecrosis of the Femoral Head: Transplantation of Autologous Mesenchymal Stem Cells Cultured With Beta‐Tricalcium Phosphate Ceramics and Free Vascularized FibulaArtificial Organs, 2006
- Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cellsGene, 2006
- Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell DifferentiationScience, 2005
- Deletion of the PDGFR-β Gene Affects Key Fibroblast Functions Important for Wound HealingJournal of Biological Chemistry, 2005
- Differential regulation of platelet‐derived growth factor stimulated migration and proliferation in osteoblastic cellsJournal of Cellular Biochemistry, 2004
- Differential growth factor control of bone formation through osteoprogenitor differentiationBone, 2004
- Collagen Integrin Receptors Regulate Early Osteoblast Differentiation Induced by BMP-2Journal of Bone and Mineral Research, 1999
- Effect of platelet‐derived growth factor‐BB on bone formation in calvarial defects: an experimental study in rabbitsEuropean Journal of Oral Sciences, 1997